$1.36
0.064.62%
Last update: Nov 6, 7:54 PM
CalciMedica Inc
CALCNASDAQ
The average analyst price target for CalciMedica is $74, 5301.5% above the current price. Of 5 analysts, 4 rate it Buy and 1 Hold. Targets range from $45 to $110. The latest change came on Aug 20, 2026, when Guggenheim initiated coverage of CalciMedica with a Buy rating and a $45 price target.
Price Target Range — 9 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
